Publications

• Hypokalemic Nephropathy.
  Kidney Int Rep Volume: 3 Page(s): 1482 - 1488
  11/01/2018 Authors: Yalamanchili HB; Calp-Inal S; Zhou XJ; Choudhury D
• The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation.
  Volume: 89 Page(s): 209 - 216
  01/01/2016 Authors: Calp-Inal S; Ajaimy M; Melamed ML; Savchik C; Masiakos P; Colovai A; Akalin E
• Improving the Predictive Value of the Virtual Crossmatch: Is the C1Q Assay Needed?
  Volume: 15
  05/01/2015 Authors: Colovai A; Savchik C; Masiakos P; Calp-Inal S; Kayler L; Akalin E
• The Prevalence and Clinical Significance of C1q Binding Donor-Specific Anti-HLA Antibodies in Patients With Functioning Allografts More Than 5 Years After Kidney Transplantation
  Volume: 98 Page(s): 83 - 84
  07/15/2014 Authors: Calp-Inal S; Colovai A; Melamed M; Masiakos P; Turgut D; Akalin E
• The Prevalence and Clinical Significance of C1q Binding Donor-Specific Anti-HLA Antibodies in Patients With Functioning Allografts More Than 5 Years After Kidney Transplantation.
  Volume: 14 Page(s): 83 - 84
  06/01/2014 Authors: Calp-Inal S; Colovai A; Melamed M; Masiakos P; Turgut D; Akalin E
• IS Clq BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODIES STILL CLINICALLY RELEVANT MORE THAN 10 YEARS AFTER KIDNEY TRANSPLANTATION?
  Volume: 63 Page(s): A35 - A35
  05/01/2014 Authors: Calp-Inal S; Colavai A; Melamed M; Akalin E